跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lamotrigine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lamotrigine
Approved
STANDARD
Lamotrigine
IPCA Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7b8c7b246ed2f2d2
Company
IPCA Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
7b8c7b246ed2f2d2
Drug Approval Philippines Name
Lamotrigine
Product Name
Lamotrigine
Registration Number
DRP-6770
Brand Name
Lamotrigine
Generic Name
Lamepil-25
Dosage Form
Tablet
Dosage Strength
25 mg
Manufacturer
IPCA Laboratories Ltd.
Importer
Blue Global (FZE)
Distributor
Blue Global (FZE)
Company Detail Path
/organization/ipca-laboratories-ltd
Issuance Date
21 May 2021
Expiry Date
27 July 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7b8c7b246ed2f2d2
Type
Standard
Back to Philippines FDA Approvals